Market Overview:
The global biologic and medical imaging reagents market is expected to grow at a CAGR of 6.5% from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of chronic diseases, rising demand for early diagnosis and treatment, and technological advancements in the field of medical imaging. Based on type, the nuclear imaging (PET & SPECT) reagents segment is expected to account for the largest share of the global biologic and medical imaging reagents market in 2018. This segment is projected to grow at a CAGR of 7.1% from 2018 to 2030 due to increasing use of PET scans for cancer diagnosis and treatment planning. Based on application, hospitals are expected to account for the largest share of the global biologic and medical imaging reagents market in 2018. This segment is projected grow at a CAGRof 6%.
Product Definition:
Biologic and medical imaging reagents are used to detect, diagnose and monitor diseases. They are important because they can help identify problems early on and help doctors treat patients more effectively.
Nuclear Imaging (PET & SPECT) Reagents:
The global nuclear imaging (PET & SPECT) reagents, it's usage and growth factor in biologic and medical imaging reagents market size was valued at USD 1.5 billion in 2015. The increasing prevalence of target diseases such as cancer, cardiovascular disorders, neurological disorders & diabetes is expected to drive the demand for diagnostic procedures over the forecast period.
Magnetic Resonance Imaging (MRI) Reagents:
Magnetic resonance imaging reagents comprise of high-intensity magnetic fields and radio waves used for visualizing soft tissues. The reagents are segmented into two types on the basis of their usage in MRI machines and PET/CT scanners.
Application Insights:
The other application segment includes research institutes and diagnostic centers. The other segment held the largest market share in 2017, as this is where research-based products are used for routine diagnostics and patient management. This also includes self-referral or walk-in patients who have not been diagnosed by a healthcare professional yet. Routine diagnostics of chronic diseases such as cancer require the use of biologic and medical imaging reagents to obtain accurate results, which contributes to its large share in clinical applications.
The hospitals segment is expected to grow at a lucrative rate over the forecast period due to increasing investments by governments across various countries toward building state-of-the art hospitals that provide better treatment facilities for patients with complex requirements, thereby driving demand for imaging reagents used in these facilities during diagnosis or preclinical testing procedures.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a large number of key players, high adoption rate for advanced diagnostic technologies, and availability of well-developed healthcare infrastructure. In addition, increasing prevalence of cancer is expected to drive regional growth during the forecast period. For instance, according to statistics published by American Cancer Society in 2018’s edition about 1 million new cases were estimated to be diagnosed in U.S., with approximately 600 thousand men and 130 thousand women are anticipated to die due annually thereafter till 2030 from various cancers including prostate cancer (2% increase), breast cancer (1% increase), colorectal cancer (4% increase) and lungcancer (3%) among others).
Growth Factors:
- Increasing demand for biologic and medical imaging reagents in the life science research market.
- Growing prevalence of chronic diseases such as cancer, diabetes, and cardiovascular diseases is expected to drive the demand for biologic and medical imaging reagents over the forecast period.
- Rising number of diagnostic procedures owing to increasing awareness about early diagnosis is anticipated to boost the growth of this market during the forecast period.
- Technological advancements in biologic and medical imaging reagents are projected to create new opportunities for this market during the forecast period.
Scope Of The Report
Report Attributes
Report Details
Report Title
Biologic and Medical Imaging Reagents Market Research Report
By Type
Nuclear Imaging (PET & SPECT) Reagents, Magnetic Resonance Imaging (MRI) Reagents, Fluorescence Imaging Reagents, Ultrasound and X-ray Contrast Reagents, Other
By Application
Hospitals, Clinics, Other
By Companies
Cardinal Health, Bracco, Bayer HealthCare, Curium Pharma, Hengrui Medicine, GE Healthcare, Lantheus Medical Imaging, Novartis (AAA), Thermo Fisher Scientific, Jubilant DraxImage, PerkinElmer, Guerbet, Nihon Medi-Physics, YRPG
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
181
Number of Tables & Figures
127
Customization Available
Yes, the report can be customized as per your need.
Global Biologic and Medical Imaging Reagents Market Report Segments:
The global Biologic and Medical Imaging Reagents market is segmented on the basis of:
Types
Nuclear Imaging (PET & SPECT) Reagents, Magnetic Resonance Imaging (MRI) Reagents, Fluorescence Imaging Reagents, Ultrasound and X-ray Contrast Reagents, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Cardinal Health
- Bracco
- Bayer HealthCare
- Curium Pharma
- Hengrui Medicine
- GE Healthcare
- Lantheus Medical Imaging
- Novartis (AAA)
- Thermo Fisher Scientific
- Jubilant DraxImage
- PerkinElmer
- Guerbet
- Nihon Medi-Physics
- YRPG
Highlights of The Biologic and Medical Imaging Reagents Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Nuclear Imaging (PET & SPECT) Reagents
- Magnetic Resonance Imaging (MRI) Reagents
- Fluorescence Imaging Reagents
- Ultrasound and X-ray Contrast Reagents
- Other
- By Application:
- Hospitals
- Clinics
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Biologic and Medical Imaging Reagents Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Biologic and medical imaging reagents are chemicals or biological substances that are used in medical imaging procedures. These substances can be used to create images of organs, tissues, or other body parts.
Some of the major companies in the biologic and medical imaging reagents market are Cardinal Health, Bracco, Bayer HealthCare, Curium Pharma, Hengrui Medicine, GE Healthcare, Lantheus Medical Imaging, Novartis (AAA), Thermo Fisher Scientific, Jubilant DraxImage, PerkinElmer, Guerbet, Nihon Medi-Physics, YRPG.
The biologic and medical imaging reagents market is expected to grow at a compound annual growth rate of 6.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Biologic and Medical Imaging Reagents Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Biologic and Medical Imaging Reagents Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Biologic and Medical Imaging Reagents Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Biologic and Medical Imaging Reagents Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Biologic and Medical Imaging Reagents Market Size & Forecast, 2020-2028 4.5.1 Biologic and Medical Imaging Reagents Market Size and Y-o-Y Growth 4.5.2 Biologic and Medical Imaging Reagents Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Nuclear Imaging (PET & SPECT) Reagents
5.2.2 Magnetic Resonance Imaging (MRI) Reagents
5.2.3 Fluorescence Imaging Reagents
5.2.4 Ultrasound and X-ray Contrast Reagents
5.2.5 Other
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Clinics
6.2.3 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Biologic and Medical Imaging Reagents Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Biologic and Medical Imaging Reagents Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Nuclear Imaging (PET & SPECT) Reagents
9.6.2 Magnetic Resonance Imaging (MRI) Reagents
9.6.3 Fluorescence Imaging Reagents
9.6.4 Ultrasound and X-ray Contrast Reagents
9.6.5 Other
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Clinics
9.10.3 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Nuclear Imaging (PET & SPECT) Reagents
10.6.2 Magnetic Resonance Imaging (MRI) Reagents
10.6.3 Fluorescence Imaging Reagents
10.6.4 Ultrasound and X-ray Contrast Reagents
10.6.5 Other
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Clinics
10.10.3 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Nuclear Imaging (PET & SPECT) Reagents
11.6.2 Magnetic Resonance Imaging (MRI) Reagents
11.6.3 Fluorescence Imaging Reagents
11.6.4 Ultrasound and X-ray Contrast Reagents
11.6.5 Other
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Clinics
11.10.3 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Nuclear Imaging (PET & SPECT) Reagents
12.6.2 Magnetic Resonance Imaging (MRI) Reagents
12.6.3 Fluorescence Imaging Reagents
12.6.4 Ultrasound and X-ray Contrast Reagents
12.6.5 Other
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Clinics
12.10.3 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Nuclear Imaging (PET & SPECT) Reagents
13.6.2 Magnetic Resonance Imaging (MRI) Reagents
13.6.3 Fluorescence Imaging Reagents
13.6.4 Ultrasound and X-ray Contrast Reagents
13.6.5 Other
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Clinics
13.10.3 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Biologic and Medical Imaging Reagents Market: Competitive Dashboard
14.2 Global Biologic and Medical Imaging Reagents Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Cardinal Health
14.3.2 Bracco
14.3.3 Bayer HealthCare
14.3.4 Curium Pharma
14.3.5 Hengrui Medicine
14.3.6 GE Healthcare
14.3.7 Lantheus Medical Imaging
14.3.8 Novartis (AAA)
14.3.9 Thermo Fisher Scientific
14.3.10 Jubilant DraxImage
14.3.11 PerkinElmer
14.3.12 Guerbet
14.3.13 Nihon Medi-Physics
14.3.14 YRPG